| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41581-020-0323-4 |
| P698 | PubMed publication ID | 32778788 |
| P50 | author | Carel le Roux | Q19544968 |
| Neil G. Docherty | Q38546401 | ||
| P2860 | cites work | Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects | Q22250885 |
| Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase | Q24309462 | ||
| Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review | Q24801508 | ||
| Adipokines as a link between obesity and chronic kidney disease | Q26825339 | ||
| Long-term mortality after gastric bypass surgery | Q28241874 | ||
| Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery | Q29614192 | ||
| Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. | Q30249819 | ||
| Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database | Q33533529 | ||
| Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass | Q33799812 | ||
| Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects | Q34033254 | ||
| Adiponectin: more than just another fat cell hormone? | Q34217331 | ||
| Bariatric surgery versus conventional medical therapy for type 2 diabetes | Q34263754 | ||
| Gastric bypass surgery is followed by lowered blood pressure and increased diuresis - long term results from the Swedish Obese Subjects (SOS) study | Q34499711 | ||
| Roux-en-Y Esophagojejunostomy Ameliorates Renal Function Through Reduction of Renal Inflammatory and Fibrotic Markers in Diabetic Nephropathy. | Q53302682 | ||
| Stimulatory effect of insulin on renal proximal tubule sodium transport is preserved in type 2 diabetes with nephropathy. | Q53548155 | ||
| Biliopancreatic Diversion is associated with greater increases in energy expenditure than Roux-en-Y Gastric Bypass. | Q55023874 | ||
| Prevalence of Proteinuria and Albuminuria in an Obese Population and Associated Risk Factors. | Q55112204 | ||
| Lower Renal Function Is Associated With Derangement of 11-β Hydroxysteroid Dehydrogenase in Type 2 Diabetes. | Q55494452 | ||
| Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer | Q57107261 | ||
| Physiology, pathophysiology and therapeutic implications of enteroendocrine control of food intake | Q57133061 | ||
| Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria | Q57737342 | ||
| Adiponectin and Bariatric Surgery: Associations With Diabetes and Cardiovascular Disease in the Swedish Obese Subjects Study | Q58418621 | ||
| Nutritional Deficiencies after Gastric Bypass: Mechanisms Involved and Strategies to Improve Oral Supplement Disposition | Q58605540 | ||
| Delivery outcomes in term births after bariatric surgery: Population-based matched cohort study | Q58696150 | ||
| Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease | Q64059484 | ||
| Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients | Q84960989 | ||
| Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials | Q88688834 | ||
| Downregulation of lncRNA MALAT1 contributes to renal functional improvement after duodenal-jejunal bypass in a diabetic rat model | Q88747509 | ||
| Obesity, kidney dysfunction and hypertension: mechanistic links | Q90253318 | ||
| Bariatric surgery and chronic kidney disease: much hope, but proof is still awaited | Q90294791 | ||
| Impact of Early Postbariatric Surgery Acute Kidney Injury on Long-Term Renal Function | Q90456987 | ||
| The Effects of Bariatric Surgery on Renal Outcomes: a Systematic Review and Meta-analysis | Q90583627 | ||
| Perioperative Risks of Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass Among Patients With Chronic Kidney Disease: A Review of the MBSAQIP Database | Q90626832 | ||
| Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies | Q90909445 | ||
| Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials | Q91042293 | ||
| Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial | Q91069220 | ||
| Effect of Surgical Versus Medical Therapy on Diabetic Kidney Disease Over 5 Years in Severely Obese Adolescents With Type 2 Diabetes | Q91104064 | ||
| Leptin and Aldosterone | Q91207960 | ||
| Temporal effects of laparoscopic sleeve gastrectomy on adipokines, inflammation, and oxidative stress in patients with impaired glucose homeostasis | Q91231441 | ||
| Severe Chronic Kidney Disease Is Associated with a Lower Efficiency of Bariatric Surgery | Q91238953 | ||
| Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery | Q91283319 | ||
| Metabolic Surgery Reduces the Risk of Progression From Chronic Kidney Disease to Kidney Failure | Q91764384 | ||
| The endocrine function of adipose tissues in health and cardiometabolic disease | Q91810395 | ||
| Metabolic surgery improves renal injury independent of weight loss: a meta-analysis | Q92143440 | ||
| Trends in Bariatric Surgery Procedures among Patients with ESKD in the United States | Q92184128 | ||
| Long-term adverse events after sleeve gastrectomy or gastric bypass: a 7-year nationwide, observational, population-based, cohort study | Q92429712 | ||
| Higher body mass index is associated with incident diabetes and chronic kidney disease independent of genetic confounding | Q92534129 | ||
| Relationship between maternal global nutrient restriction during pregnancy and offspring kidney structure and function: a systematic review of animal studies | Q93000135 | ||
| Serum uromodulin and Roux-en-Y gastric bypass: improvement of a marker reflecting nephron mass | Q93021415 | ||
| Bariatric Surgery Does Not Affect Food Preferences, but Individual Changes in Food Preferences May Predict Weight Loss | Q93027258 | ||
| Increase of the Adiponectin/Leptin Ratio in Patients with Obesity and Type 2 Diabetes after Roux-en-Y Gastric Bypass | Q93102769 | ||
| SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis | Q93178701 | ||
| Bariatric Surgery and Long-term Survival in Patients With Obesity and End-stage Kidney Disease | Q95852134 | ||
| Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity: A Randomized Clinical Trial | Q96121329 | ||
| Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations | Q34528123 | ||
| Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression | Q34534899 | ||
| Combining GFR and albuminuria to classify CKD improves prediction of ESRD. | Q34606387 | ||
| The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial | Q34848978 | ||
| Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials | Q35024182 | ||
| Kidney stones are common after bariatric surgery | Q35243688 | ||
| Gastrointestinal changes after bariatric surgery. | Q35340286 | ||
| Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study | Q35479461 | ||
| Roux-en-Y Gastric Bypass Surgery Increases Respiratory Quotient and Energy Expenditure during Food Intake. | Q35670800 | ||
| Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial | Q35771371 | ||
| Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes | Q35804201 | ||
| Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis | Q35903126 | ||
| Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice | Q36453507 | ||
| Role of the Paraventricular Nucleus of the Hypothalamus in the Sympathoexcitatory Effects of Leptin | Q36702603 | ||
| Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes | Q36723318 | ||
| Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial | Q36784428 | ||
| Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study | Q36865845 | ||
| Treatment of Obesity: Weight Loss and Bariatric Surgery | Q36956145 | ||
| Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial | Q36998556 | ||
| Body mass index in 1.2 million adolescents and risk for end-stage renal disease | Q37085746 | ||
| A proposed clinical staging system for obesity | Q37384280 | ||
| Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). | Q37634009 | ||
| Baseline characteristics of participants in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study. | Q37708725 | ||
| Obesity in kidney transplant recipients and candidates | Q37746311 | ||
| Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery | Q38060843 | ||
| Bariatric surgery to treat obesity | Q38078550 | ||
| Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease | Q38209300 | ||
| Review article: The nutritional and pharmacological consequences of obesity surgery. | Q38235543 | ||
| Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4. | Q38236209 | ||
| Birth weight, malnutrition and kidney-associated outcomes--a global concern. | Q38323305 | ||
| Enteric hyperoxaluria: an important cause of end-stage kidney disease | Q38363406 | ||
| Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Second IFSO Global Registry Report 2013-2015. | Q38398940 | ||
| Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study | Q38412110 | ||
| Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications | Q38428629 | ||
| The management of patients with enteric hyperoxaluria | Q38662272 | ||
| Incidence of Successful Pregnancy After Weight Loss Interventions in Infertile Women: a Systematic Review and Meta-Analysis of the Literature. | Q38667665 | ||
| Reconfiguration of the small intestine and diabetes remitting effects of Roux-en-Y gastric bypass surgery | Q38721342 | ||
| Urinary sodium excretion after gastric bypass surgery | Q38750192 | ||
| Bariatric Surgery as a Bridge to Renal Transplantation in Patients with End-Stage Renal Disease | Q38788490 | ||
| Regarding Obesity as a Disease: Evolving Policies and Their Implications | Q38926140 | ||
| The impact of insulin resistance on the kidney and vasculature | Q38982413 | ||
| Leptin in inflammation and autoimmunity | Q39028988 | ||
| Preoperative Fasting Plasma C-Peptide Levels as Predictors of Remission of Type 2 Diabetes Mellitus after Bariatric Surgery: A Systematic Review and Meta-Analysis | Q39043144 | ||
| A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. | Q39130791 | ||
| Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy. | Q39833131 | ||
| Sodium and water handling after gastric bypass surgery in a rat model | Q41900187 | ||
| Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass | Q42449157 | ||
| Neprilysin, obesity and the metabolic syndrome | Q42610866 | ||
| Diabetic kidney disease. | Q43721013 | ||
| Ethnic-specific obesity cutoffs for diabetes risk: cross-sectional study of 490,288 UK biobank participants | Q44330574 | ||
| Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. | Q44398229 | ||
| Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance | Q44563290 | ||
| Body mass index and risk for end-stage renal disease | Q46876497 | ||
| 11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome | Q47098934 | ||
| Effect of Roux-en-Y gastric bypass and diet-induced weight loss on diabetic kidney disease in the Zucker diabetic fatty rat. | Q47271736 | ||
| Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters | Q47356520 | ||
| Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). | Q47406858 | ||
| Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes | Q47419942 | ||
| Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial | Q47547235 | ||
| Effect of Bariatric Surgery on CKD Risk | Q47563194 | ||
| Extravascular renal denervation ameliorates juvenile hypertension and renal damage resulting from experimental hyperleptinemia in rats | Q47700216 | ||
| Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor. | Q47885313 | ||
| Metabolic Effects of Bariatric Surgery | Q47957300 | ||
| Meta-analysis of metabolic surgery versus medical treatment for microvascular complications in patients with type 2 diabetes mellitus | Q48100238 | ||
| Gastric bypass surgery elevates NT-ProBNP levels | Q48141578 | ||
| Transcutaneous assessment of renal function in conscious rats with a device for measuring FITC-sinistrin disappearance curves | Q48282466 | ||
| Immunologic and endocrine functions of adipose tissue: implications for kidney disease | Q49334065 | ||
| Maternal and Neonatal Outcomes After Bariatric Surgery; A Systematic Review and Meta-Analysis: Do the benefits outweigh the risks? | Q49895807 | ||
| Leptin and brain-adipose crosstalks. | Q49957598 | ||
| Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort. | Q51102437 | ||
| Renal function is ameliorated in a diabetic nephropathy rat model through a duodenal-jejunal bypass. | Q51328949 | ||
| Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy. | Q51749724 | ||
| Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate | Q52381850 | ||
| Decreases in neprilysin and vasoconstrictors and increases in vasodilators following bariatric surgery. | Q52590307 | ||
| Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. | Q52675077 | ||
| Interdisciplinary European guidelines on metabolic and bariatric surgery. | Q53102466 | ||
| Simplified Method to Measure Glomerular Filtration Rate by Iohexol Plasma Clearance in Conscious Rats. | Q53103502 | ||
| P921 | main subject | chronic renal insufficiency | Q736715 |
| type 2 diabetes | Q3025883 | ||
| P577 | publication date | 2020-08-10 | |
| P1433 | published in | Nature Reviews Nephrology | Q2079275 |
| P1476 | title | Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus |
| Q101410033 | Remission and progression of pre-existing micro- and macroalbuminuria over 15 years after bariatric surgery in Swedish Obese Subjects study | cites work | P2860 |
Search more.